Skyrizi 600 mg/10mL (Risankizumab-Rzaa INJECTION) 600 mg/10mL

Skyrizi 600 mg/10mL is a risankizumab-rzaa injection used for managing specific inflammatory conditions. This single-dose vial is designed for intravenous administration, offering a convenient treatment option.

Strength

600 mg/10mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Skyrizi 600 mg/10mL is primarily used for managing moderate to severe plaque psoriasis. This medication targets specific proteins involved in the inflammatory process, helping to reduce symptoms. Patients often ask, 'What is Skyrizi used for?' and the answer includes managing chronic inflammatory conditions beyond psoriasis, such as psoriatic arthritis.

Side Effects

Common effects of Skyrizi 600 mg/10mL may include injection site reactions, upper respiratory infections, and fatigue. Some users report improvements in skin clarity and reduced joint pain over time. Individual responses can vary, and it's important to monitor for any unusual symptoms.

Precautions & Warnings

Skyrizi 600 mg/10mL should be handled with care, ensuring proper storage and administration by healthcare professionals. Patients with a history of infections or allergies should discuss their medical history with their healthcare provider before use. Always follow the prescribed guidelines for safe and effective use.

Avoid Interactions

Skyrizi 600 mg/10mL may interact with other medications, particularly those that affect the immune system. It's important to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also influence the effectiveness of this medication.

Frequently Asked Questions

Skyrizi is primarily used for managing moderate to severe plaque psoriasis and may also be used for other inflammatory conditions.

Skyrizi is administered via intravenous injection, typically by a healthcare professional.

Common side effects may include injection site reactions, upper respiratory infections, and fatigue.

Skyrizi may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Skyrizi should be stored as per the manufacturer's instructions, typically in a refrigerator until ready for use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.